CorVel Corporation

CRVL US Health Care Health Care Services
S&P 600
$69.27
+2.33%
Delayed · cached 15 min

Fair value analysis

CRVL
CorVel Corporation
Health CareHealth Care Services
$69.27
Close used for this calculation
$45.84Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
62/100
Profitability19/25
Returns12/25
Balance Sheet21/25
Efficiency10/25
Growth9/25
Good
Quality radar
62Prof.19/25Ret.12/25Eff.10/25B.Sht21/25Growth9/25

Consensus fair value

$45.84
Above FV
▼ -33.8% against the close used
Model range $31.97 – $61.05
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$31.97Fair value$45.84Bull$61.05
FairClose
52-week traded range
52W low $46.0052W high $88.21

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

CorVel Corporation closed at $69.27, 51.1% above the consensus fair value of $45.84 drawn from 7 valuation models.

Financial DNA score 62/100 — Good. P/E of 32.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$42.45
-38.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
P/E Fair Value
$42.80
-38.2%
EPS × 20x (sector P/E)
EPS=2.14, Sector P/E=20x
Peter Lynch (PEG)
$38.95
-43.8%
EPS × Growth% (PEG = 1 is fair)
EPS=2.14, g=18.2%
EV/EBITDA
$61.05
-11.9%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=174.9M
Book Value (P/B)
$42.12
-39.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=8.03, ROE=27%, g=6%, r=10%
Reverse DCF
$69.27
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 13.6% | Historical: 18.2%
Margin of Safety
$31.97
-53.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=42.63, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.